Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TOCA

Tocagen (TOCA) Stock Price, News & Analysis

Tocagen logo

About Tocagen Stock (NASDAQ:TOCA)

Advanced Chart

Key Stats

Today's Range
$12.20
$13.20
50-Day Range
$1.26
$41.03
52-Week Range
$0.42
$6.77
Volume
31,369 shs
Average Volume
1.47 million shs
Market Capitalization
$298.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TOCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tocagen and its competitors with MarketBeat's FREE daily newsletter.

TOCA Stock News Headlines

Forte Biosciences Inc (FBRX)
Trump’s July 22 order
White House to reset Social Security? President Trump's inner circle has a plan that could radically change how Social Security works. In fact, just days after taking office, President Trump signed Executive Order 14179 - giving his team new powers to permanently reset how many key federal agencies work. That reset is now ready to begin - and it's critical you start preparing your money immediately.
RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying
See More Headlines

TOCA Stock Analysis - Frequently Asked Questions

Tocagen Inc (NASDAQ:TOCA) posted its earnings results on Thursday, April, 23rd. The company reported ($0.43) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.44) by $0.01. Tocagen had a negative net margin of 176,433.34% and a negative trailing twelve-month return on equity of 327.74%.

Tocagen (TOCA) raised $80 million in an IPO on Thursday, April 13th 2017. The company issued 7,300,000 shares at $10.00-$12.00 per share. Leerink Partners, Evercore ISI and Stifel served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tocagen investors own include VBI Vaccines (VBIV), Selecta Biosciences (SELB), Inovio Pharmaceuticals (INO), SCYNEXIS (SCYX), T2 Biosystems (TTOO), Bristol Myers Squibb (BMY) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
4/23/2020
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TOCA
CIK
1419041
Fax
N/A
Employees
77
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.52 million
Net Margins
-176,433.34%
Pretax Margin
N/A
Return on Equity
-327.74%
Return on Assets
-111.87%

Debt

Debt-to-Equity Ratio
1.88
Current Ratio
1.15
Quick Ratio
1.15

Sales & Book Value

Annual Sales
$40 thousand
Price / Sales
7,462.73
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
27.73

Miscellaneous

Outstanding Shares
23,919,000
Free Float
N/A
Market Cap
$298.51 million
Optionable
Not Optionable
Beta
0.01
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:TOCA) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners